Our results reveal that in addition to FasL, Foxo3a mRNA levels are elevated in mutant Hdh cells and 3-NP-treated cortical neurons and most importantly in HD patient post-mortem caudate nucleus. This evidence concerns the gene FOXO3 and Huntington disease.